Anti-Human Follistatin

Leinco Technologies
Product Code: LEI-F1120
Product Group: Primary Antibodies
CodeSizePrice
LEI-F1120-25ug25 ug£420.00
Quantity:
LEI-F1120-100ug100 ug£694.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Caprine (Goat)
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Immunohistochemistry (IHC)
  • Neutralisation
  • Western Blot (WB)
Shipping:
Ambient
Storage:
The lyophilized antigen affinity purified polyclonal antibody can be stored desiccated at -20°C to -70°C for twelve months from date of receipt. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. No detectable loss of activity was observed after six months.

Images

1 / 1

Further Information

Conjugate/Tag/Label:
Antigen Affinity Purified
Format:
This antigen affinity purified polyclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.4 containing 5.0% w/v trehalose with no calcium, magnesium, or preservatives present.
Formulation:
This antigen affinity purified polyclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.4 containing 5.0% w/v trehalose with no calcium, magnesium, or preservatives present.
Immunogen:
Purified Recombinant Human Follistatin, aa 30 - 329 (>98%)
NCBI Gene:
10468
Target:
Follistatin

Related Products

Product NameProduct CodeSupplier 
Human Follistatin ELISA Development KitLEI-F1103Leinco Technologies Summary Details
Anti-Human Follistatin - BiotinLEI-F1125Leinco Technologies Summary Details
Anti-Human Follistatin (Clone 85918)LEI-F1133Leinco Technologies Summary Details
Recombinant Mouse FollistatinLEI-F1191Leinco Technologies Summary Details
Recombinant Human FollistatinLEI-F168Leinco Technologies Summary Details